AU2001290586A1 - Compositions and methods relating to hypertension - Google Patents

Compositions and methods relating to hypertension

Info

Publication number
AU2001290586A1
AU2001290586A1 AU2001290586A AU9058601A AU2001290586A1 AU 2001290586 A1 AU2001290586 A1 AU 2001290586A1 AU 2001290586 A AU2001290586 A AU 2001290586A AU 9058601 A AU9058601 A AU 9058601A AU 2001290586 A1 AU2001290586 A1 AU 2001290586A1
Authority
AU
Australia
Prior art keywords
hypertension
compositions
methods relating
relating
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290586A
Inventor
Jorge Capdevila
Vijakumar Holla
Michael Waterman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of AU2001290586A1 publication Critical patent/AU2001290586A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001290586A 2000-08-29 2001-08-29 Compositions and methods relating to hypertension Abandoned AU2001290586A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22894700P 2000-08-29 2000-08-29
US60228947 2000-08-29
PCT/US2001/026914 WO2002017856A2 (en) 2000-08-29 2001-08-29 Compositions and methods relating to hypertension

Publications (1)

Publication Number Publication Date
AU2001290586A1 true AU2001290586A1 (en) 2002-03-13

Family

ID=22859206

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290586A Abandoned AU2001290586A1 (en) 2000-08-29 2001-08-29 Compositions and methods relating to hypertension

Country Status (3)

Country Link
US (1) US20020165208A1 (en)
AU (1) AU2001290586A1 (en)
WO (1) WO2002017856A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814318A (en) * 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5770429A (en) * 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
EP0814159B1 (en) * 1990-08-29 2005-07-27 GenPharm International, Inc. Transgenic mice capable of producing heterologous antibodies
US5789650A (en) * 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
AU672969B2 (en) * 1992-03-10 1996-10-24 United States of America, as represented by The Secretary, Department of Health & Human Services, The Exchangeable template reaction
US5663425A (en) * 1996-01-26 1997-09-02 Lignotech Usa, Inc. Production of acid soluble humates

Also Published As

Publication number Publication date
WO2002017856A3 (en) 2002-06-13
US20020165208A1 (en) 2002-11-07
WO2002017856A2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
AU2002357119A1 (en) Mitocidal compositions and methods
AUPQ419099A0 (en) Novel compositions and methods
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2778801A (en) Antisense compositions and methods
AU2001291222A1 (en) Wax-modified thermosettable compositions
AU2001253179A1 (en) Defoamer compositions and uses therefor
AU6618900A (en) Compositions useful as desiccants and methods relating thereto
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2001233932A1 (en) Method and composition
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2002239775A1 (en) Chemical-library composition and method
AU2001235764A1 (en) Compositions
AU2002332507A1 (en) Levothyroxine compositions and methods
AU2001234685A1 (en) Methods and compositions for enhancing formyltetrahydropteroylpolyglutamate in plants
AU2001290586A1 (en) Compositions and methods relating to hypertension
AU2003268078A1 (en) Levothyroxine compositions and methods
AU2002236534A1 (en) Compositions and methods relating to ovary specific genes and proteins
AU2000251520A1 (en) Antiviral methods and compositions
AU2002359869A1 (en) Pak5-related compositions and methods
AU2001249194A1 (en) Immunokine composition and method